Another relevant genetic variant related to progressive NAFLD is the transmembrane 6 superfamily member 2 (TM6SF2), which is responsible for lipid retention and impairment of very low-density lipoprotein (VLDL) release by liver [29]. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.